Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Ampicillin
Drug ID BADD_D00133
Description Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
Indications and Usage For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc
Marketing Status approved; vet_approved
ATC Code J01CA01; S01AA19
DrugBank ID DB00415
KEGG ID D00204
MeSH ID D000667
PubChem ID 6249
TTD Drug ID D0YA9Z
NDC Product Code 0781-2145; 82449-512; 0781-2144; 66794-221; 66794-222; 67457-351; 67457-352; 70518-2607; 44567-104; 66794-223; 71872-7240; 82449-902; 44567-101; 44567-103; 82449-511; 71872-7249; 25021-136; 44567-102; 51662-1560; 66794-220; 72572-017; 82449-903; 25021-137; 51662-1595; 66794-224; 72572-016
UNII 7C782967RD
Synonyms Ampicillin | Aminobenzylpenicillin | Penicillin, Aminobenzyl | Aminobenzyl Penicillin | Ampicillin Sodium | Sodium, Ampicillin | Ampicillin Trihydrate | Trihydrate, Ampicillin | Antibiotic KS-R1 | Antibiotic KS R1 | KS-R1, Antibiotic | Pentrexyl | Polycillin | Ukapen | Amcill | Omnipen
Chemical Information
Molecular Formula C16H19N3O4S
CAS Registry Number 69-53-4
SMILES CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agranulocytosis01.02.03.001--Not Available
Anaemia01.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.009--Not Available
Aphthous ulcer07.05.06.002--Not Available
Body temperature increased13.15.01.001--Not Available
Bronchospasm22.03.01.004; 10.01.03.012--
Circulatory collapse24.06.02.001--Not Available
Colitis07.08.01.001--
Coma17.02.09.001--Not Available
Cyanosis02.11.04.004; 23.06.04.005; 24.03.01.007; 22.02.02.007--
Dermatitis23.03.04.002--Not Available
Dermatitis allergic23.03.04.003; 10.01.03.014--Not Available
Dermatitis bullous23.03.01.002--
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Drug eruption23.03.05.001; 10.01.01.005; 08.01.06.015--Not Available
Drug hypersensitivity10.01.01.0010.075707%Not Available
Drug interaction08.06.03.001--Not Available
Drug withdrawal syndrome neonatal19.07.06.014; 18.04.13.001; 08.06.02.008--Not Available
Enteritis07.08.03.002--
Enterocolitis07.08.03.003--
Eosinophilia01.02.04.001--
Erythema23.03.06.0010.000758%Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Eyelid oedema23.04.01.003; 10.01.05.001; 06.04.04.004--Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.003--
Faeces discoloured07.01.03.002--Not Available
The 1th Page    1 2 3    Next   Last    Total 3 Pages